- Home
- IOVA vs FBRT Comparison
IOVA vs FBRT Comparison
Compare IOVA & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IOVA | FBRT |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 882.8M |
| IPO Year | N/A | 1985 |
Fundamental Metrics
Financial Performance| Metric | IOVA | FBRT |
|---|---|---|
| Price | $2.22 | $10.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $10.36 | ★ $14.75 |
| AVG Volume (30 Days) | ★ 16.6M | 742.6K |
| Earning Date | 11-06-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 13.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | ★ $250,425,000.00 | $241,051,000.00 |
| Revenue This Year | $60.94 | $28.41 |
| Revenue Next Year | $60.85 | $50.77 |
| P/E Ratio | ★ N/A | $13.16 |
| Revenue Growth | ★ 175.62 | 32.77 |
| 52 Week Low | $1.64 | $9.71 |
| 52 Week High | $9.30 | $13.58 |
Technical Indicators
Market Signals| Indicator | IOVA | FBRT |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 59.05 |
| Support Level | $2.13 | $10.28 |
| Resistance Level | $2.55 | $10.45 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 25.57 | 83.94 |
Price Performance
Historical ComparisonAbout IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.